Compounds > n-acetylgalactosaminyl-1-4-n-acetylglucosamine
Page last updated: 2024-09-03

n-acetylgalactosaminyl-1-4-n-acetylglucosamine and Benign Neoplasms

n-acetylgalactosaminyl-1-4-n-acetylglucosamine has been researched along with Benign Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cabrita, EJ; Carvalho, AL; Coelho, H; Corzana, F; Dias, JS; Diniz, A; Gimeno, A; Jiménez-Barbero, J; Lima, CDL; Marcelo, F; Trovão, F1
Furukawa, K; Hirano, K; Matsuda, A; Shirai, T1

Reviews

1 review(s) available for n-acetylgalactosaminyl-1-4-n-acetylglucosamine and Benign Neoplasms

ArticleYear
Expression of LacdiNAc groups on N-glycans among human tumors is complex.
    BioMed research international, 2014, Volume: 2014

    Topics: Cell Transformation, Neoplastic; Humans; Lactose; Neoplasms; Polysaccharides

2014

Other Studies

1 other study(ies) available for n-acetylgalactosaminyl-1-4-n-acetylglucosamine and Benign Neoplasms

ArticleYear
Structural Insights into the Molecular Recognition Mechanism of the Cancer and Pathogenic Epitope, LacdiNAc by Immune-Related Lectins.
    Chemistry (Weinheim an der Bergstrasse, Germany), 2021, May-20, Volume: 27, Issue:29

    Topics: Epitopes; Humans; Lactose; Neoplasms; Polysaccharides; Protein Binding

2021